Edgen Stock·Dec 13 2025, 00:56Back
Amgen Uplizna Approval Boosts Autoimmune Pipeline
Edgen Stock·Dec 13 2025, 00:56
[1] Amgen Scores Uplizna Expansion Into Generalized Myasthenia Gravis - BioSpace (https://www.biospace.com/fda/amgen-scores-upl ...)[2] Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 December 2025 - European Medicines Agency (https://www.ema.europa.eu/en/news/meeting-hig ...)[3] Emergent BioSolutions (NYSE: EBS) gains FDA OK for Winnipeg raxibacumab drug product site - Stock Titan (https://www.stocktitan.net/news/EBS/emergent- ...)
